FoxHollow Technologies to Participate in William Blair Growth Stock Conference
June 27 2006 - 5:15PM
PR Newswire (US)
REDWOOD CITY, Calif., June 27 /PRNewswire-FirstCall/ -- FoxHollow
Technologies (NASDAQ:FOXH), which manufactures and markets the
SilverHawk(TM) Plaque Excision System, a minimally invasive device
for the treatment of peripheral artery disease (PAD), is scheduled
to participate in the 26th Annual William Blair & Company
Growth Stock Conference on Thursday, June 29, 2006, in Chicago,
Illinois. Dr. John Simpson, chief executive officer, will provide
an update on the company at 1:50 p.m. Central Time (2:50 p.m.
Eastern Time). A live audio webcast of the presentation will be
available via the Internet at http://investor.foxhollowtech.com/
and will be available for replay for approximately three months.
About FoxHollow Technologies FoxHollow Technologies, Inc., develops
and markets minimally invasive plaque excision devices for the
treatment of peripheral artery disease (PAD). An estimated 12
million people in the U.S. are thought to suffer from PAD, with 2.5
million patients currently diagnosed. PAD results from plaque that
accumulates in the arteries and blocks blood flow in the legs.
These blockages can result in severe pain for patients and very
limited physical mobility. The company's SilverHawk system is a
minimally invasive method of removing the obstructive plaque and
restoring blood flow to the legs and feet. For more information,
please visit our website at http://www.foxhollowtech.com/. Contacts
Investor Relations: Matt Ferguson Chief Financial Officer
650-421-8449 Media Relations: Robin Gaffney 650-421-8614
DATASOURCE: FoxHollow Technologies, Inc. CONTACT: investors, Matt
Ferguson, Chief Financial Officer, +1-650-421-8449, or , or media,
Robin Gaffney, +1-650-421-8614, or , both of FoxHollow
Technologies, Inc. Web site: http://www.foxhollowtech.com/
Copyright
Foxhollow (NASDAQ:FOXH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Foxhollow (NASDAQ:FOXH)
Historical Stock Chart
From Jul 2023 to Jul 2024